Grant Pickering
Founder at VAXCYTE, INC.
Net worth: 53 M $ as of 2024-03-30
Grant Pickering active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VAXCYTE, INC. | Director/Board Member | 2013-05-26 | - |
| Chief Executive Officer | 2013-05-26 | - | |
| Founder | 2013-05-26 | - | |
| President | 2013-05-26 | 2020-12-31 | |
| ATHIRA PHARMA, INC. | Director/Board Member | 2022-01-26 | - |
| Independent Dir/Board Member | 2022-01-26 | - |
Career history of Grant Pickering
Former positions of Grant Pickering
| Companies | Position | Start | End |
|---|---|---|---|
| MYMETICS CORPORATION | Director/Board Member | 2012-03-21 | 2012-11-18 |
| Chief Executive Officer | 2012-03-21 | 2012-11-18 | |
| President | 2012-03-21 | 2012-11-18 | |
| DENDREON CORPORATION | Chief Operating Officer | - | 2005-11-17 |
Juvaris BioTherapeutics, Inc.
 Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Director/Board Member | 2008-03-13 | - |
| Chief Executive Officer | 2008-03-13 | - | |
| President | 2008-03-13 | - |
Training of Grant Pickering
| The Pennsylvania State University | Undergraduate Degree |
| Georgetown University | Masters Business Admin |
Statistics
International
| United States | 7 |
| Switzerland | 2 |
Operational
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| President | 3 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| MYMETICS CORPORATION | Health Technology |
| ATHIRA PHARMA, INC. | Health Technology |
| VAXCYTE, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Juvaris BioTherapeutics, Inc.
Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Health Technology |
- Stock Market
- Insiders
- Grant Pickering
- Experience